Rossmax International Ltd. (TPEX:4121)
12.75
+0.05 (0.39%)
Sep 18, 2026, 1:30 PM CST
Rossmax International Market Cap
Rossmax International has a market cap or net worth of 1.05 billion as of September 17, 2026. Its market cap has decreased by -14.27% in one year.
Market Cap
1.05B
Enterprise Value
2.16B
Revenue
3.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.75
ChartMarket Cap Chart
Since September 2, 2003, Rossmax International's market cap has decreased from 1.67B to 1.05B, a decrease of -37.11%. That is a compound annual growth rate of -1.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.05B | -18.59% |
| Dec 31, 2025 | 1.29B | -14.14% |
| Dec 31, 2024 | 1.50B | -29.19% |
| Dec 29, 2023 | 2.12B | 2.25% |
| Dec 30, 2022 | 2.08B | 16.71% |
| Dec 30, 2021 | 1.78B | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.52B |
| NaviFUS | 1.49B |
| AViTA | 1.37B |
| Bioptik Technology Incorporation | 1.33B |
| S&S Healthcare Holding | 1.19B |
| Wiltrom | 961.96M |
| Diamond Biotechnology | 893.36M |
| AmCad BioMed | 874.00M |